Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis
Status:
Terminated
Trial end date:
2018-03-22
Target enrollment:
Participant gender:
Summary
This is an experimental study, prospective, comparative. This clinical trial is randomized
and double-blind, Residronate versus placebo.
The study aims to demonstrate the effectiveness of risedronate in pain management, after 18
month of traitment, in patients undergoing aseptic joint prosthesis loosening. 2 groups were
compared with a 1: 1 ratio. The first group receives active drug (risedronate 75mg) and the
second a placebo.
Patients are treated during 18 months: 1 tablet residronate/placebo per os two consecutive
days each month.
Evaluations are planned evry 6 months.